IFP Advisors, Inc - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$896
-97.6%
10
-97.7%
0.00%
-100.0%
Q2 2023$37,519
+38.8%
426
+43.4%
0.00%0.0%
Q1 2023$27,029
+103857.7%
297
+18.8%
0.00%0.0%
Q4 2022$26
-99.9%
250
+6.8%
0.00%0.0%
Q3 2022$24,000
+14.3%
234
+3.5%
0.00%0.0%
Q2 2022$21,000
-4.5%
226
-4.2%
0.00%
Q1 2022$22,0002360.00%
Q2 2021$000.00%
Q1 2021$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q4 2020$62,000
+785.7%
530
+531.0%
0.00%
Q3 2020$7,000
+133.3%
84
+162.5%
0.00%
Q2 2020$3,0000.0%32
+45.5%
0.00%
Q1 2020$3,000220.00%
Q4 2019$0
-100.0%
0
-100.0%
0.00%
Q3 2019$3,0000.0%26
-36.6%
0.00%
Q1 2019$3,000
+200.0%
41
+241.7%
0.00%
Q4 2018$1,000
-92.3%
12
-89.4%
0.00%
-100.0%
Q3 2018$13,000
-38.1%
113
-52.1%
0.00%0.0%
Q2 2018$21,000
-4.5%
236
-39.0%
0.00%0.0%
Q1 2018$22,0000.0%3870.0%0.00%0.0%
Q4 2017$22,000
+29.4%
3870.0%0.00%0.0%
Q3 2017$17,000
+13.3%
3870.0%0.00%0.0%
Q2 2017$15,000
+200.0%
387
+219.8%
0.00%
Q1 2017$5,0000.0%1210.0%0.00%
Q4 2016$5,0000.0%121
-10.4%
0.00%
Q3 2016$5,000
+400.0%
135
+400.0%
0.00%
Q2 2016$1,000
-66.7%
27
-34.1%
0.00%
Q1 2016$3,000
+200.0%
41
+51.9%
0.00%
Q4 2015$1,000270.00%
Other shareholders
HAEMONETICS CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders